Soleno Therapeutics, Inc. (SLNO)
Soleno Therapeutics Market Cap : 2.723B for April 24, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Neurocrine Biosciences, Inc. | 12.90B |
| Nektar Therapeutics | 1.554B |
| Forian, Inc. | 67.48M |
| Boston Scientific Corp. | 93.38B |
| Integer Holdings Corp. | 2.923B |
Market Cap Related Metrics
| PE Ratio | 236.76 |
| PS Ratio | 14.26 |
| Price to Book Value | 6.050 |
| Price to Free Cash Flow | 58.19 |
| Price | 52.75 |
| Earnings Yield | 0.42% |
| Operating PE Ratio | 181.64 |
| Normalized PE Ratio | 174.73 |